Effect of Tranexamic acid on mortality and morbidity in spontaneously ICH patients

Phase 3

Recruiting

• Conditions: Intracerebral hemorrhage.; Nontraumatic intracerebral hemorrhage in hemisphere, subcortical; I61.0

• Registration Number: IRCT20191014045103N1
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 December 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 94

Inclusion Criteria

Spontaneous ICH Patients Refer to Emergency Department of Arak Amiralmomenin Hospital in Arak

Exclusion Criteria

The patient is a candidate for surgery
Patient with documented cerebral venous thrombosis (CVT) and documented venous thrombosis

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Duration of hospitalization. Timepoint: After the injection. Method of measurement: Admitted by checklist as number of days hospitalization.;Evaluation of the patient's clinical condition. Timepoint: After the injection. Method of measurement: Checklist and NIHSS questionnaire.